Shijiazhuang Yiling Pharmaceutical Co Ltd Working Capital to Net Assets Ratio
Shijiazhuang Yiling Pharmaceutical Co Ltd working capital to net assets ratio. Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) has a Working Capital to Net Assets ratio of 28.8% as of June 2026. Working capital of CN¥3.14 Billion (current assets of CN¥5.74 Billion minus current liabilities of CN¥2.61 Billion) is measured against net assets of CN¥10.90 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check how tangible is Shijiazhuang Yiling Pharmaceutical Co Lt's equity to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Shijiazhuang Yiling Pharmaceutical Co Ltd (2008–2025)
Working capital to net assets ratio of Shijiazhuang Yiling Pharmaceutical Co Ltd from 2008 to 2025. This chart shows how Shijiazhuang Yiling Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 18 annual periods from 2008 to 2025. As of June 2026, the ratio stands at 28.8%, reflecting working capital of CN¥3.14 Billion against net assets of CN¥10.90 Billion CNY. See 002603 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Shijiazhuang Yiling Pharmaceutical Co Ltd Working Capital to Net Assets Ratio by Year (2008–2025)
Shijiazhuang Yiling Pharmaceutical Co Ltd working capital to net assets ratio by year from 2008 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Shijiazhuang Yiling Pharmaceutical Co Ltd from 2008 to 2025, covering 18 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Shijiazhuang Yiling Pharmaceutical Co Lt asset portfolio.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 27.3% | CN¥3.00 Billion | CN¥10.98 Billion | CN¥5.21 Billion | CN¥2.21 Billion | ▲ +10.4 pp |
| 2024 | 16.9% | CN¥1.73 Billion | CN¥10.20 Billion | CN¥4.33 Billion | CN¥2.61 Billion | ▼ -1.4 pp |
| 2023 | 18.3% | CN¥2.10 Billion | CN¥11.44 Billion | CN¥6.54 Billion | CN¥4.45 Billion | ▼ -3.7 pp |
| 2022 | 22.0% | CN¥2.40 Billion | CN¥10.93 Billion | CN¥7.25 Billion | CN¥4.85 Billion | ▼ -7.1 pp |
| 2021 | 29.1% | CN¥2.64 Billion | CN¥9.07 Billion | CN¥5.60 Billion | CN¥2.96 Billion | ▼ -6.9 pp |
| 2020 | 36.0% | CN¥3.22 Billion | CN¥8.92 Billion | CN¥5.46 Billion | CN¥2.24 Billion | ▼ -17.6 pp |
| 2019 | 53.6% | CN¥4.26 Billion | CN¥7.95 Billion | CN¥5.07 Billion | CN¥806.43 Million | ▼ -1.1 pp |
| 2018 | 54.7% | CN¥4.13 Billion | CN¥7.56 Billion | CN¥4.90 Billion | CN¥764.66 Million | ▲ +4.9 pp |
| 2017 | 49.8% | CN¥3.54 Billion | CN¥7.11 Billion | CN¥4.15 Billion | CN¥607.29 Million | ▲ +16.4 pp |
| 2016 | 33.4% | CN¥1.78 Billion | CN¥5.33 Billion | CN¥2.53 Billion | CN¥747.83 Million | ▼ -0.1 pp |
| 2015 | 33.5% | CN¥1.61 Billion | CN¥4.83 Billion | CN¥2.32 Billion | CN¥707.42 Million | ▼ -5.9 pp |
| 2014 | 39.3% | CN¥1.74 Billion | CN¥4.42 Billion | CN¥2.24 Billion | CN¥504.64 Million | ▼ -18.3 pp |
| 2013 | 57.7% | CN¥2.46 Billion | CN¥4.26 Billion | CN¥2.70 Billion | CN¥239.93 Million | ▼ -9.0 pp |
| 2012 | 66.7% | CN¥2.56 Billion | CN¥3.84 Billion | CN¥2.69 Billion | CN¥130.22 Million | ▼ -9.2 pp |
| 2011 | 75.9% | CN¥2.81 Billion | CN¥3.70 Billion | CN¥3.18 Billion | CN¥373.98 Million | ▲ +43.0 pp |
| 2010 | 32.9% | CN¥358.73 Million | CN¥1.09 Billion | CN¥892.83 Million | CN¥534.10 Million | ▼ -3.6 pp |
| 2009 | 36.4% | CN¥288.06 Million | CN¥790.55 Million | CN¥928.81 Million | CN¥640.75 Million | ▲ +3.9 pp |
| 2008 | 32.5% | CN¥157.30 Million | CN¥484.03 Million | CN¥445.72 Million | CN¥288.42 Million | — |